Search for a trial

A Randomized, Multicenter, Phase 3 Study of Zanidatamab in Combination with Chemotherapy with or without Tislelizumab in Subjects with HER2-positive Unresectable Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma (GEA)

This study has been transitioned to CTIS with ID 2023-510319-20-00 check the CTIS register for the current data. Primary objective:- To compare the efficacy of zanidatamab in combination with chemotherapy or in combination with chemotherapy and…